DE69827417D1 - Tizoxanide und/oder Nitazoxanide enthaltende pharmazeutische Zubereitungen - Google Patents

Tizoxanide und/oder Nitazoxanide enthaltende pharmazeutische Zubereitungen

Info

Publication number
DE69827417D1
DE69827417D1 DE69827417T DE69827417T DE69827417D1 DE 69827417 D1 DE69827417 D1 DE 69827417D1 DE 69827417 T DE69827417 T DE 69827417T DE 69827417 T DE69827417 T DE 69827417T DE 69827417 D1 DE69827417 D1 DE 69827417D1
Authority
DE
Germany
Prior art keywords
tizoxanides
nitazoxanides
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69827417T
Other languages
English (en)
Other versions
DE69827417T2 (de
Inventor
Jean-Francois Rossignol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Romark Laboratories LC
Original Assignee
Romark Laboratories LC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69827417(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Laboratories LC filed Critical Romark Laboratories LC
Publication of DE69827417D1 publication Critical patent/DE69827417D1/de
Application granted granted Critical
Publication of DE69827417T2 publication Critical patent/DE69827417T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69827417T 1997-05-07 1998-05-06 Tizoxanide und/oder Nitazoxanide enthaltende pharmazeutische Zubereitungen Expired - Lifetime DE69827417T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US852447 1997-05-07
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US887810 1997-07-03
US887809 1997-07-03

Publications (2)

Publication Number Publication Date
DE69827417D1 true DE69827417D1 (de) 2004-12-09
DE69827417T2 DE69827417T2 (de) 2005-10-27

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69827417T Expired - Lifetime DE69827417T2 (de) 1997-05-07 1998-05-06 Tizoxanide und/oder Nitazoxanide enthaltende pharmazeutische Zubereitungen
DE69809928T Expired - Lifetime DE69809928T2 (de) 1997-05-07 1998-05-06 Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69809928T Expired - Lifetime DE69809928T2 (de) 1997-05-07 1998-05-06 Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen

Country Status (35)

Country Link
EP (2) EP1222921B1 (de)
JP (1) JP3739802B2 (de)
KR (2) KR100426657B1 (de)
CN (2) CN1158074C (de)
AP (1) AP1103A (de)
AR (1) AR057242A2 (de)
AT (2) ATE281166T1 (de)
AU (1) AU740022B2 (de)
BG (2) BG109365A (de)
BR (1) BR9808722A (de)
CA (2) CA2418634C (de)
CZ (2) CZ298269B6 (de)
DE (2) DE69827417T2 (de)
DK (2) DK1222921T3 (de)
EA (2) EA002920B1 (de)
EE (1) EE04870B1 (de)
ES (2) ES2232687T3 (de)
GE (1) GEP20032970B (de)
HK (1) HK1025907A1 (de)
HU (1) HU229641B1 (de)
IL (2) IL155799A (de)
IS (1) IS2087B (de)
LV (1) LV12492B (de)
ME (1) ME00530B (de)
NO (2) NO313983B1 (de)
NZ (2) NZ500149A (de)
OA (1) OA11169A (de)
PL (1) PL193275B1 (de)
PT (2) PT1222921E (de)
RO (1) RO120605B1 (de)
SI (1) SI20149B (de)
SK (2) SK283947B6 (de)
TR (1) TR199902733T2 (de)
UA (2) UA57079C2 (de)
WO (1) WO1998050035A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2636527C (en) 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
PE20121118A1 (es) 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
EP2445349B1 (de) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Verbindungen und verfahren zur behandlung von influenza
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
AU2015346413B2 (en) * 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (de) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimerzusammensetzungen und verfahren zur behandlung von augenerkrankungen
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
KR20040004544A (ko) 2004-01-13
UA57079C2 (uk) 2003-06-16
AU740022B2 (en) 2001-10-25
KR100576646B1 (ko) 2006-05-08
NO335781B1 (no) 2015-02-16
HK1025907A1 (en) 2000-12-01
DE69809928T2 (de) 2003-04-24
SK283947B6 (sk) 2004-05-04
EP1005342A4 (de) 2001-02-07
UA74388C2 (uk) 2005-12-15
GEP20032970B (en) 2003-05-27
IL155799A (en) 2004-08-31
SI20149B (en) 2001-08-31
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
NO20021832D0 (no) 2002-04-18
BR9808722A (pt) 2000-07-11
CA2288003A1 (en) 1998-11-12
CZ298270B6 (cs) 2007-08-08
IL155799A0 (en) 2003-12-23
JP2001503067A (ja) 2001-03-06
CA2418634A1 (en) 1998-11-12
CZ391199A3 (cs) 2000-07-12
SK283946B6 (sk) 2004-05-04
EA199901012A1 (ru) 2000-08-28
OA11169A (en) 2003-04-25
KR100426657B1 (ko) 2004-04-13
DE69809928D1 (de) 2003-01-16
ES2150404T3 (es) 2003-07-01
CN1255060A (zh) 2000-05-31
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
CN1552322A (zh) 2004-12-08
NO995406D0 (no) 1999-11-04
CN100515420C (zh) 2009-07-22
NZ500149A (en) 2001-11-30
AP1103A (en) 2002-09-04
EP1222921A1 (de) 2002-07-17
EA002920B1 (ru) 2002-10-31
BG109365A (en) 2006-08-31
SI20149A (sl) 2000-08-31
BG64973B1 (bg) 2006-11-30
PT1005342E (pt) 2003-02-28
PT1222921E (pt) 2005-02-28
DK1005342T3 (da) 2003-03-24
CZ298269B6 (cs) 2007-08-08
TR199902733T2 (xx) 2000-03-21
EP1222921B1 (de) 2004-11-03
SK151199A3 (en) 2000-07-11
ES2232687T3 (es) 2005-06-01
CA2288003C (en) 2003-10-21
LV12492B (en) 2001-01-20
DE69827417T2 (de) 2005-10-27
WO1998050035A1 (en) 1998-11-12
NZ513881A (en) 2002-10-25
EE04870B1 (et) 2007-08-15
EA200100956A1 (ru) 2002-02-28
NO995406L (no) 2000-01-04
EP1005342B1 (de) 2002-12-04
IL132516A (en) 2003-12-10
ES2150404T1 (es) 2000-12-01
IL132516A0 (en) 2001-03-19
RO120605B1 (ro) 2006-05-30
HUP0003330A2 (hu) 2001-05-28
IS5223A (is) 1999-10-19
CN1158074C (zh) 2004-07-21
JP3739802B2 (ja) 2006-01-25
ATE228839T1 (de) 2002-12-15
IS2087B (is) 2006-03-15
AR057242A2 (es) 2007-11-21
KR20010020322A (ko) 2001-03-15
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
NO313983B1 (no) 2003-01-13
HU229641B1 (en) 2014-03-28
EA002908B1 (ru) 2002-10-31
EP1005342A1 (de) 2000-06-07
EE9900578A (et) 2000-08-15
LV12492A (en) 2000-06-20
PL336805A1 (en) 2000-07-17
ME00530B (me) 2011-10-10
PL193275B1 (pl) 2007-01-31
ATE281166T1 (de) 2004-11-15
DK1222921T3 (da) 2005-03-07

Similar Documents

Publication Publication Date Title
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
BR1100824A (pt) Composto e composição farmacêutica
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE59813619D1 (de) Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
DE59407193D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE285762T1 (de) Kombinationspräparate enthaltend statin und karboxyalkyläther
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE69827417D1 (de) Tizoxanide und/oder Nitazoxanide enthaltende pharmazeutische Zubereitungen
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE50006823D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69722433D1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
NO995838D0 (no) Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
DE50011647D1 (de) Kosmetische und/oder pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8380 Miscellaneous part iii

Free format text: DINGLICHES RECHT WURDE BESTELLT